Quick Answer
LianBio reported Net Income of -$110.29 million for fiscal year 2022.
LianBio Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2022 | -$110.29M | +43.8% |
| 2021 | -$196.30M | -40.6% |
| 2020 | -$139.60M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$24.04M | -9.8% | -11.2% |
| June 30, 2023 | -$21.62M | +49.0% | +10.1% |
| March 31, 2023 | -$24.05M | +13.3% | -9.8% |
| September 30, 2022 | -$21.90M | -67.0% | +48.3% |
| June 30, 2022 | -$42.39M | +57.8% | -52.9% |
| March 31, 2022 | -$27.73M | +55.0% | -111.5% |
| September 30, 2021 | -$13.11M | — | +86.9% |
| June 30, 2021 | -$100.43M | — | -63.1% |
- LianBio showed an increase of +43.8% in Net Income compared to the prior fiscal year.
- Over the 2020–2022 period, LianBio’s net income has grown by 21.0% (from -$139.60 million to -$110.29 million).
- The most recent figure is from LianBio’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 28, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: